-
Mashup Score: 92023 IKCS: North America to feature three special awards - Kidney Cancer Association - 6 month(s) ago
The 2023 International Kidney Cancer Symposium: North America will feature three special awards honoring standout members of the kidney cancer community.
Source: www.kidneycancer.orgCategories: General Medicine News, UrologyTweet
-
Mashup Score: 0Home | KCJ - 7 month(s) ago
Aberrant hypoxia signaling orchestrates metabolic reprogramming in clear cell renal cell carcinoma to support glycogen and lipid accumulation.
Source: kidney-cancer-journal.comCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 2Campbell RA et al Q2 2023 | KCJ - 10 month(s) ago
ABSTRACT Renal mass in a solitary kidney is a challenging clinical scenario and partial nephrectomy (PN) is generally prioritized. For tumors with high complexity, an in vivo approach with hypothermia is most often preferred at our center. Ex vivo PN is another option although results with this approach have varied and its utility in this setting is not well defined. We present the case of a…
Source: kidney-cancer-journal.comCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 1Home | KCJ - 10 month(s) ago
× Subscription Sign Up Sign Up Feel free to choose as many as you like. Newsletter Print Copy of KCJ electronic KCJ Terms of Service * Agree to…
Source: kidney-cancer-journal.comCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 2Home | KCJ - 1 year(s) ago
× Subscription Sign Up Sign Up Feel free to choose as many as you like. Newsletter Print Copy of KCJ electronic KCJ Terms of Service * Agree to…
Source: kidney-cancer-journal.comCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 1Ravindra et al Q1 2023 | KCJ - 1 year(s) ago
Submitted – October 18, 2022 | Revised December 4, 2022 Accepted – December 7, 2022 | | ePublished – December 31, 2022 https://doi.org/10.52733/KCJ21n1-r1 ABSTRACT Renal Cell Carcinoma (RCC) is among the most frequently…
Source: kidney-cancer-journal.comCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 1Ravindra et al Q1 2023 | KCJ - 1 year(s) ago
Submitted – Februray 14, 2023 | Revised March 9, 2023 | Revised Manuscript Accepted – March 15, 2023 | ePublished – March 30, 2023 https://doi.org/10.52733/KCJ21n1-a1 ABSTRACT Chromophobe renal cell carcinoma (chRCC) is a rare histologic…
Source: kidney-cancer-journal.comCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0SUBMIT MANUSCRIPT TO KCJ | KCJ - 1 year(s) ago
× Subscription Sign Up Sign Up Feel free to choose as many as you like. Newsletter Print Copy of KCJ electronic KCJ Terms of Service * Agree to…
Source: kidney-cancer-journal.comCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0EDITOR MEMO DEC 2022 | KCJ - 1 year(s) ago
Dear Colleagues, This year’s IKCS2022 Annual meeting offered a dynamic agenda unveiling the latest scientific advances and pivotal data from a broad spectrum of topics in kidney cancers, including a significant amount of emerging data on renal cell carcinoma. From early-phase clinical trials to updates on novel therapeutics, the sessions offered a unique opportunity to gauge progress on a…
Source: kidney-cancer-journal.comCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0Zhang et al Q4 2022 | KCJ - 1 year(s) ago
Submitted – October 18, 2022 | Revised December 4, 2022 Accepted – December 7, 2022 | | ePublished – December 31, 2022 https://doi.org/10.52733/KCJ20n4-r Benjamin T. Berger, MD1,*, Michael R. Harrison, MD1,2, Matthew K. Labriola, MD1,2 1) Department of Medicine, Duke University…
Source: kidney-cancer-journal.comCategories: Latest Headlines, UrologyTweet
🥳Congratulations to special career awards recipients: 👏Dr. Nizar Tannir, 👏@PavlosMsaouel, 👏@uretericbud Read @KidneyCancer press release: https://t.co/pjWYpP4Jrk @IKCSNA23 @MDAndersonNews @FoxChaseCancer https://t.co/rgqUfeBBXG https://t.co/ooVcLmCJE1